 | • レポートコード：GIR-107A11974 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍マーカーイムノアッセイのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍マーカーイムノアッセイの種類別市場規模（ProGRP、PSA（複合体、遊離、合計）、SCC（扁平上皮癌抗原）、血清HER-2/neu、サイログロブリン、CA 72-4、その他）、用途別市場規模（肝臓がん、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍マーカーイムノアッセイの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Clarity Diagnostics, LLC、CTK Biotech, Inc、DIALAB GmbH、Ortho Clinical Diagnostics、Polymedco, Inc、DIAsource ImmunoAssays SA、DRG International, Inc、Fujirebio US, Inc、Bioscience (Tianjin) Diagnostic Technology Co., Ltd、Boson Biotech Co., Ltd、Qualigen, Inc、Randox Laboratories, Ltd、Roche Diagnostic Corporation、Siemens Healthineers、Syntron Bioresearch, Inc、Teco Diagnostics、Thermo Fisher Scientific, Inc、Tosoh Bioscience, Inc、Diametra、DiaSorin S.p.A ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ProGRP、PSA（複合体、遊離、合計）、SCC（扁平上皮癌抗原）、血清HER-2/neu、サイログロブリン、CA 72-4、その他 ・用途別分析2016年-2026年：肝臓がん、乳がん、その他 ・腫瘍マーカーイムノアッセイの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍マーカーイムノアッセイのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍マーカーイムノアッセイのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍マーカーイムノアッセイの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍マーカーイムノアッセイの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tumor Markers Immunoassay market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tumor Markers Immunoassay size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Tumor Markers Immunoassay market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tumor Markers Immunoassay market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
Others
Market segment by Application, can be divided into
Liver Cancer
Breast Cancer
Others
Market segment by players, this report covers
Clarity Diagnostics, LLC
CTK Biotech, Inc
DIALAB GmbH
Ortho Clinical Diagnostics
Polymedco, Inc
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen, Inc
Randox Laboratories, Ltd
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific, Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin S.p.A
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Tumor Markers Immunoassay product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Tumor Markers Immunoassay, with revenue, gross margin and global market share of Tumor Markers Immunoassay from 2019 to 2021.
Chapter 3, the Tumor Markers Immunoassay competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Tumor Markers Immunoassay market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Tumor Markers Immunoassay research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Tumor Markers Immunoassay
1.2 Classification of Tumor Markers Immunoassay by Type
1.2.1 Overview: Global Tumor Markers Immunoassay Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Tumor Markers Immunoassay Revenue Market Share by Type in 2020
1.2.3 ProGRP
1.2.4 PSA (complexed, free, total))
1.2.5 SCC (squamous cell carcinoma antigen)
1.2.6 Serum HER-2/neu
1.2.7 Thyroglobulin
1.2.8 CA 72-4
1.2.9 Others
1.3 Global Tumor Markers Immunoassay Market by Application
1.3.1 Overview: Global Tumor Markers Immunoassay Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Global Tumor Markers Immunoassay Market Size & Forecast
1.5 Global Tumor Markers Immunoassay Market Size and Forecast by Region
1.5.1 Global Tumor Markers Immunoassay Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Tumor Markers Immunoassay Market Size by Region, (2016-2021)
1.5.3 North America Tumor Markers Immunoassay Market Size and Prospect (2016-2026)
1.5.4 Europe Tumor Markers Immunoassay Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Tumor Markers Immunoassay Market Size and Prospect (2016-2026)
1.5.6 South America Tumor Markers Immunoassay Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Tumor Markers Immunoassay Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tumor Markers Immunoassay Market Drivers
1.6.2 Tumor Markers Immunoassay Market Restraints
1.6.3 Tumor Markers Immunoassay Trends Analysis
2 Company Profiles
2.1 Clarity Diagnostics, LLC
2.1.1 Clarity Diagnostics, LLC Details
2.1.2 Clarity Diagnostics, LLC Major Business
2.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Product and Solutions
2.1.4 Clarity Diagnostics, LLC Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Clarity Diagnostics, LLC Recent Developments and Future Plans
2.2 CTK Biotech, Inc
2.2.1 CTK Biotech, Inc Details
2.2.2 CTK Biotech, Inc Major Business
2.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Product and Solutions
2.2.4 CTK Biotech, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 CTK Biotech, Inc Recent Developments and Future Plans
2.3 DIALAB GmbH
2.3.1 DIALAB GmbH Details
2.3.2 DIALAB GmbH Major Business
2.3.3 DIALAB GmbH Tumor Markers Immunoassay Product and Solutions
2.3.4 DIALAB GmbH Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 DIALAB GmbH Recent Developments and Future Plans
2.4 Ortho Clinical Diagnostics
2.4.1 Ortho Clinical Diagnostics Details
2.4.2 Ortho Clinical Diagnostics Major Business
2.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Product and Solutions
2.4.4 Ortho Clinical Diagnostics Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.5 Polymedco, Inc
2.5.1 Polymedco, Inc Details
2.5.2 Polymedco, Inc Major Business
2.5.3 Polymedco, Inc Tumor Markers Immunoassay Product and Solutions
2.5.4 Polymedco, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Polymedco, Inc Recent Developments and Future Plans
2.6 DIAsource ImmunoAssays SA
2.6.1 DIAsource ImmunoAssays SA Details
2.6.2 DIAsource ImmunoAssays SA Major Business
2.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Product and Solutions
2.6.4 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 DIAsource ImmunoAssays SA Recent Developments and Future Plans
2.7 DRG International, Inc
2.7.1 DRG International, Inc Details
2.7.2 DRG International, Inc Major Business
2.7.3 DRG International, Inc Tumor Markers Immunoassay Product and Solutions
2.7.4 DRG International, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 DRG International, Inc Recent Developments and Future Plans
2.8 Fujirebio US, Inc
2.8.1 Fujirebio US, Inc Details
2.8.2 Fujirebio US, Inc Major Business
2.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Product and Solutions
2.8.4 Fujirebio US, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Fujirebio US, Inc Recent Developments and Future Plans
2.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
2.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Details
2.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Major Business
2.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Product and Solutions
2.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Developments and Future Plans
2.10 Boson Biotech Co., Ltd
2.10.1 Boson Biotech Co., Ltd Details
2.10.2 Boson Biotech Co., Ltd Major Business
2.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Product and Solutions
2.10.4 Boson Biotech Co., Ltd Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Boson Biotech Co., Ltd Recent Developments and Future Plans
2.11 Qualigen, Inc
2.11.1 Qualigen, Inc Details
2.11.2 Qualigen, Inc Major Business
2.11.3 Qualigen, Inc Tumor Markers Immunoassay Product and Solutions
2.11.4 Qualigen, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Qualigen, Inc Recent Developments and Future Plans
2.12 Randox Laboratories, Ltd
2.12.1 Randox Laboratories, Ltd Details
2.12.2 Randox Laboratories, Ltd Major Business
2.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Product and Solutions
2.12.4 Randox Laboratories, Ltd Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Randox Laboratories, Ltd Recent Developments and Future Plans
2.13 Roche Diagnostic Corporation
2.13.1 Roche Diagnostic Corporation Details
2.13.2 Roche Diagnostic Corporation Major Business
2.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Product and Solutions
2.13.4 Roche Diagnostic Corporation Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Roche Diagnostic Corporation Recent Developments and Future Plans
2.14 Siemens Healthineers
2.14.1 Siemens Healthineers Details
2.14.2 Siemens Healthineers Major Business
2.14.3 Siemens Healthineers Tumor Markers Immunoassay Product and Solutions
2.14.4 Siemens Healthineers Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Siemens Healthineers Recent Developments and Future Plans
2.15 Syntron Bioresearch, Inc
2.15.1 Syntron Bioresearch, Inc Details
2.15.2 Syntron Bioresearch, Inc Major Business
2.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Product and Solutions
2.15.4 Syntron Bioresearch, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Syntron Bioresearch, Inc Recent Developments and Future Plans
2.16 Teco Diagnostics
2.16.1 Teco Diagnostics Details
2.16.2 Teco Diagnostics Major Business
2.16.3 Teco Diagnostics Tumor Markers Immunoassay Product and Solutions
2.16.4 Teco Diagnostics Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Teco Diagnostics Recent Developments and Future Plans
2.17 Thermo Fisher Scientific, Inc
2.17.1 Thermo Fisher Scientific, Inc Details
2.17.2 Thermo Fisher Scientific, Inc Major Business
2.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Product and Solutions
2.17.4 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Thermo Fisher Scientific, Inc Recent Developments and Future Plans
2.18 Tosoh Bioscience, Inc
2.18.1 Tosoh Bioscience, Inc Details
2.18.2 Tosoh Bioscience, Inc Major Business
2.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Product and Solutions
2.18.4 Tosoh Bioscience, Inc Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Tosoh Bioscience, Inc Recent Developments and Future Plans
2.19 Diametra
2.19.1 Diametra Details
2.19.2 Diametra Major Business
2.19.3 Diametra Tumor Markers Immunoassay Product and Solutions
2.19.4 Diametra Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Diametra Recent Developments and Future Plans
2.20 DiaSorin S.p.A
2.20.1 DiaSorin S.p.A Details
2.20.2 DiaSorin S.p.A Major Business
2.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Product and Solutions
2.20.4 DiaSorin S.p.A Tumor Markers Immunoassay Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 DiaSorin S.p.A Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tumor Markers Immunoassay Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Tumor Markers Immunoassay Players Market Share
3.2.2 Top 10 Tumor Markers Immunoassay Players Market Share
3.2.3 Market Competition Trend
3.3 Tumor Markers Immunoassay Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tumor Markers Immunoassay Revenue and Market Share by Type (2016-2021)
4.2 Global Tumor Markers Immunoassay Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Tumor Markers Immunoassay Revenue Market Share by Application (2016-2021)
5.2 Tumor Markers Immunoassay Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Tumor Markers Immunoassay Revenue by Type (2016-2026)
6.2 North America Tumor Markers Immunoassay Revenue by Application (2016-2026)
6.3 North America Tumor Markers Immunoassay Market Size by Country
6.3.1 North America Tumor Markers Immunoassay Revenue by Country (2016-2026)
6.3.2 United States Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
6.3.3 Canada Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
6.3.4 Mexico Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Tumor Markers Immunoassay Revenue by Type (2016-2026)
7.2 Europe Tumor Markers Immunoassay Revenue by Application (2016-2026)
7.3 Europe Tumor Markers Immunoassay Market Size by Country
7.3.1 Europe Tumor Markers Immunoassay Revenue by Country (2016-2026)
7.3.2 Germany Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
7.3.3 France Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
7.3.5 Russia Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
7.3.6 Italy Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tumor Markers Immunoassay Revenue by Type (2016-2026)
8.2 Asia-Pacific Tumor Markers Immunoassay Revenue by Application (2016-2026)
8.3 Asia-Pacific Tumor Markers Immunoassay Market Size by Region
8.3.1 Asia-Pacific Tumor Markers Immunoassay Revenue by Region (2016-2026)
8.3.2 China Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8.3.3 Japan Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8.3.4 South Korea Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8.3.5 India Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
8.3.7 Australia Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Tumor Markers Immunoassay Revenue by Type (2016-2026)
9.2 South America Tumor Markers Immunoassay Revenue by Application (2016-2026)
9.3 South America Tumor Markers Immunoassay Market Size by Country
9.3.1 South America Tumor Markers Immunoassay Revenue by Country (2016-2026)
9.3.2 Brazil Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
9.3.3 Argentina Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tumor Markers Immunoassay Revenue by Type (2016-2026)
10.2 Middle East & Africa Tumor Markers Immunoassay Revenue by Application (2016-2026)
10.3 Middle East & Africa Tumor Markers Immunoassay Market Size by Country
10.3.1 Middle East & Africa Tumor Markers Immunoassay Revenue by Country (2016-2026)
10.3.2 Turkey Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
10.3.4 UAE Tumor Markers Immunoassay Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Tumor Markers Immunoassay Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Tumor Markers Immunoassay Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Tumor Markers Immunoassay Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Tumor Markers Immunoassay Revenue (USD Million) by Region (2016-2021)
Table 5. Global Tumor Markers Immunoassay Revenue Market Share by Region (2021-2026)
Table 6. Clarity Diagnostics, LLC Corporate Information, Head Office, and Major Competitors
Table 7. Clarity Diagnostics, LLC Major Business
Table 8. Clarity Diagnostics, LLC Tumor Markers Immunoassay Product and Solutions
Table 9. Clarity Diagnostics, LLC Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. CTK Biotech, Inc Corporate Information, Head Office, and Major Competitors
Table 11. CTK Biotech, Inc Major Business
Table 12. CTK Biotech, Inc Tumor Markers Immunoassay Product and Solutions
Table 13. CTK Biotech, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. DIALAB GmbH Corporate Information, Head Office, and Major Competitors
Table 15. DIALAB GmbH Major Business
Table 16. DIALAB GmbH Tumor Markers Immunoassay Product and Solutions
Table 17. DIALAB GmbH Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 19. Ortho Clinical Diagnostics Major Business
Table 20. Ortho Clinical Diagnostics Tumor Markers Immunoassay Product and Solutions
Table 21. Ortho Clinical Diagnostics Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Polymedco, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Polymedco, Inc Major Business
Table 24. Polymedco, Inc Tumor Markers Immunoassay Product and Solutions
Table 25. Polymedco, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. DIAsource ImmunoAssays SA Corporate Information, Head Office, and Major Competitors
Table 27. DIAsource ImmunoAssays SA Major Business
Table 28. DIAsource ImmunoAssays SA Tumor Markers Immunoassay Product and Solutions
Table 29. DIAsource ImmunoAssays SA Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. DRG International, Inc Corporate Information, Head Office, and Major Competitors
Table 31. DRG International, Inc Major Business
Table 32. DRG International, Inc Tumor Markers Immunoassay Product and Solutions
Table 33. DRG International, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Fujirebio US, Inc Corporate Information, Head Office, and Major Competitors
Table 35. Fujirebio US, Inc Major Business
Table 36. Fujirebio US, Inc Tumor Markers Immunoassay Product and Solutions
Table 37. Fujirebio US, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 39. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Major Business
Table 40. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Product and Solutions
Table 41. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Boson Biotech Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Boson Biotech Co., Ltd Major Business
Table 44. Boson Biotech Co., Ltd Tumor Markers Immunoassay Product and Solutions
Table 45. Boson Biotech Co., Ltd Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Qualigen, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Qualigen, Inc Major Business
Table 48. Qualigen, Inc Tumor Markers Immunoassay Product and Solutions
Table 49. Qualigen, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Randox Laboratories, Ltd Corporate Information, Head Office, and Major Competitors
Table 51. Randox Laboratories, Ltd Major Business
Table 52. Randox Laboratories, Ltd Tumor Markers Immunoassay Product and Solutions
Table 53. Randox Laboratories, Ltd Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Roche Diagnostic Corporation Corporate Information, Head Office, and Major Competitors
Table 55. Roche Diagnostic Corporation Major Business
Table 56. Roche Diagnostic Corporation Tumor Markers Immunoassay Product and Solutions
Table 57. Roche Diagnostic Corporation Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 59. Siemens Healthineers Major Business
Table 60. Siemens Healthineers Tumor Markers Immunoassay Product and Solutions
Table 61. Siemens Healthineers Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Syntron Bioresearch, Inc Corporate Information, Head Office, and Major Competitors
Table 63. Syntron Bioresearch, Inc Major Business
Table 64. Syntron Bioresearch, Inc Tumor Markers Immunoassay Product and Solutions
Table 65. Syntron Bioresearch, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Teco Diagnostics Corporate Information, Head Office, and Major Competitors
Table 67. Teco Diagnostics Major Business
Table 68. Teco Diagnostics Tumor Markers Immunoassay Product and Solutions
Table 69. Teco Diagnostics Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Thermo Fisher Scientific, Inc Corporate Information, Head Office, and Major Competitors
Table 71. Thermo Fisher Scientific, Inc Major Business
Table 72. Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Product and Solutions
Table 73. Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Tosoh Bioscience, Inc Corporate Information, Head Office, and Major Competitors
Table 75. Tosoh Bioscience, Inc Major Business
Table 76. Tosoh Bioscience, Inc Tumor Markers Immunoassay Product and Solutions
Table 77. Tosoh Bioscience, Inc Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Diametra Corporate Information, Head Office, and Major Competitors
Table 79. Diametra Major Business
Table 80. Diametra Tumor Markers Immunoassay Product and Solutions
Table 81. Diametra Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. DiaSorin S.p.A Corporate Information, Head Office, and Major Competitors
Table 83. DiaSorin S.p.A Major Business
Table 84. DiaSorin S.p.A Tumor Markers Immunoassay Product and Solutions
Table 85. DiaSorin S.p.A Tumor Markers Immunoassay Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Tumor Markers Immunoassay Revenue (USD Million) by Players (2019-2021)
Table 87. Global Tumor Markers Immunoassay Revenue Share by Players (2019-2021)
Table 88. Breakdown of Tumor Markers Immunoassay by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Tumor Markers Immunoassay Players Head Office, Products and Services Provided
Table 90. Tumor Markers Immunoassay Mergers & Acquisitions in the Past Five Years
Table 91. Tumor Markers Immunoassay New Entrants and Expansion Plans
Table 92. Global Tumor Markers Immunoassay Revenue (USD Million) by Type (2016-2021)
Table 93. Global Tumor Markers Immunoassay Revenue Share by Type (2016-2021)
Table 94. Global Tumor Markers Immunoassay Revenue Forecast by Type (2021-2026)
Table 95. Global Tumor Markers Immunoassay Revenue by Application (2016-2021)
Table 96. Global Tumor Markers Immunoassay Revenue Forecast by Application (2021-2026)
Table 97. North America Tumor Markers Immunoassay Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Tumor Markers Immunoassay Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Tumor Markers Immunoassay Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Tumor Markers Immunoassay Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Tumor Markers Immunoassay Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Tumor Markers Immunoassay Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Tumor Markers Immunoassay Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Tumor Markers Immunoassay Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Tumor Markers Immunoassay Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Tumor Markers Immunoassay Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Tumor Markers Immunoassay Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Tumor Markers Immunoassay Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Tumor Markers Immunoassay Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Tumor Markers Immunoassay Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Tumor Markers Immunoassay Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Tumor Markers Immunoassay Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Tumor Markers Immunoassay Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Tumor Markers Immunoassay Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Tumor Markers Immunoassay Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Tumor Markers Immunoassay Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Tumor Markers Immunoassay Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Tumor Markers Immunoassay Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Tumor Markers Immunoassay Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Tumor Markers Immunoassay Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Tumor Markers Immunoassay Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Tumor Markers Immunoassay Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Tumor Markers Immunoassay Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Tumor Markers Immunoassay Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Tumor Markers Immunoassay Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Tumor Markers Immunoassay Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Tumor Markers Immunoassay Picture
Figure 2. Global Tumor Markers Immunoassay Revenue Market Share by Type in 2020
Figure 3. ProGRP
Figure 4. PSA (complexed, free, total))
Figure 5. SCC (squamous cell carcinoma antigen)
Figure 6. Serum HER-2/neu
Figure 7. Thyroglobulin
Figure 8. CA 72-4
Figure 9. Others
Figure 10. Tumor Markers Immunoassay Revenue Market Share by Application in 2020
Figure 11. Liver Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Others Picture
Figure 14. Global Tumor Markers Immunoassay Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Tumor Markers Immunoassay Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Tumor Markers Immunoassay Revenue Market Share by Region (2016-2026)
Figure 17. Global Tumor Markers Immunoassay Revenue Market Share by Region in 2020
Figure 18. North America Tumor Markers Immunoassay Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Tumor Markers Immunoassay Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Tumor Markers Immunoassay Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Tumor Markers Immunoassay Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Tumor Markers Immunoassay Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Tumor Markers Immunoassay Market Drivers
Figure 24. Tumor Markers Immunoassay Market Restraints
Figure 25. Tumor Markers Immunoassay Market Trends
Figure 26. Clarity Diagnostics, LLC Recent Developments and Future Plans
Figure 27. CTK Biotech, Inc Recent Developments and Future Plans
Figure 28. DIALAB GmbH Recent Developments and Future Plans
Figure 29. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 30. Polymedco, Inc Recent Developments and Future Plans
Figure 31. DIAsource ImmunoAssays SA Recent Developments and Future Plans
Figure 32. DRG International, Inc Recent Developments and Future Plans
Figure 33. Fujirebio US, Inc Recent Developments and Future Plans
Figure 34. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Developments and Future Plans
Figure 35. Boson Biotech Co., Ltd Recent Developments and Future Plans
Figure 36. Qualigen, Inc Recent Developments and Future Plans
Figure 37. Randox Laboratories, Ltd Recent Developments and Future Plans
Figure 38. Roche Diagnostic Corporation Recent Developments and Future Plans
Figure 39. Siemens Healthineers Recent Developments and Future Plans
Figure 40. Syntron Bioresearch, Inc Recent Developments and Future Plans
Figure 41. Teco Diagnostics Recent Developments and Future Plans
Figure 42. Thermo Fisher Scientific, Inc Recent Developments and Future Plans
Figure 43. Tosoh Bioscience, Inc Recent Developments and Future Plans
Figure 44. Diametra Recent Developments and Future Plans
Figure 45. DiaSorin S.p.A Recent Developments and Future Plans
Figure 46. Global Tumor Markers Immunoassay Revenue Share by Players in 2020
Figure 47. Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 48. Global Top 3 Players Tumor Markers Immunoassay Revenue Market Share in 2020
Figure 49. Global Top 10 Players Tumor Markers Immunoassay Revenue Market Share in 2020
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 51. Global Tumor Markers Immunoassay Revenue Share by Type in 2020
Figure 52. Global Tumor Markers Immunoassay Market Share Forecast by Type (2021-2026)
Figure 53. Global Tumor Markers Immunoassay Revenue Share by Application in 2020
Figure 54. Global Tumor Markers Immunoassay Market Share Forecast by Application (2021-2026)
Figure 55. North America Tumor Markers Immunoassay Sales Market Share by Type (2016-2026)
Figure 56. North America Tumor Markers Immunoassay Sales Market Share by Application (2016-2026)
Figure 57. North America Tumor Markers Immunoassay Revenue Market Share by Country (2016-2026)
Figure 58. United States Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Canada Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Mexico Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Europe Tumor Markers Immunoassay Sales Market Share by Type (2016-2026)
Figure 62. Europe Tumor Markers Immunoassay Sales Market Share by Application (2016-2026)
Figure 63. Europe Tumor Markers Immunoassay Revenue Market Share by Country (2016-2026)
Figure 64. Germany Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. France Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. United Kingdom Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Russia Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Italy Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Asia-Pacific Tumor Markers Immunoassay Sales Market Share by Type (2016-2026)
Figure 70. Asia-Pacific Tumor Markers Immunoassay Sales Market Share by Application (2016-2026)
Figure 71. Asia-Pacific Tumor Markers Immunoassay Revenue Market Share by Region (2016-2026)
Figure 72. China Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Japan Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Korea Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. India Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Southeast Asia Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Australia Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South America Tumor Markers Immunoassay Sales Market Share by Type (2016-2026)
Figure 79. South America Tumor Markers Immunoassay Sales Market Share by Application (2016-2026)
Figure 80. South America Tumor Markers Immunoassay Revenue Market Share by Country (2016-2026)
Figure 81. Brazil Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Argentina Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Middle East and Africa Tumor Markers Immunoassay Sales Market Share by Type (2016-2026)
Figure 84. Middle East and Africa Tumor Markers Immunoassay Sales Market Share by Application (2016-2026)
Figure 85. Middle East and Africa Tumor Markers Immunoassay Revenue Market Share by Country (2016-2026)
Figure 86. Turkey Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Saudi Arabia Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. UAE Tumor Markers Immunoassay Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source
世界の線維形成性小円形細胞腫瘍治療市場 2021：企業別、地域別、種類・用途別 The Desmoplastic Small Round Cell Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- 世界のウィルムス腫瘍治療市場 2021：企業別、地域別、種類・用途別 The Wilms' Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 腫瘍特異抗原の世界市場 2019年版：種類別（コーディング領域、非コーディング領域）、用途別（創薬＆開発、診断、臨床および基礎研究、その他） Scope of the Report: The global Tumor-Specific Antigen market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, al…
- 世界の犬乳腺腫瘍治療市場 2021：企業別、地域別、種類・用途別 The Canine Mammary Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Receptor Superfamily Member 9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…